The global hidradenitis suppurativa treatment market reached USD 833.60 million in 2024, with growth supported by the rising prevalence of the condition and expanding access to specialized care. Forecasted to grow at a CAGR of 4.20% from 2025 to 2034, the market is expected to see continued advancements in therapeutic solutions and patient management strategies. https://www.expertmarketresearch.com/reports/hidradenitis-suppurativa-treatment-market